Dow Up0.00% Nasdaq Up0.09%

Threshold Pharmaceuticals Inc. (THLD)

-NasdaqCM
2.90 Down 0.04(1.36%) Nov 28, 1:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 12,495   5,867   62  
Cost of Revenue -   -   -  
Gross Profit 12,495   5,867   62  
Operating Expenses
Research Development29,334  18,786  24,388  
Selling General and Administrative9,185  7,080  5,710  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (26,024) (19,999) (30,036)
Income from Continuing Operations
Total Other Income/Expenses Net(2,189)(51,136)4,383  
Earnings Before Interest And Taxes(28,213)(71,135)(25,653)
Interest Expense -   -   -  
Income Before Tax(28,213)(71,135)(25,653)
Income Tax Expense202   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(28,415)(71,135)(25,653)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (28,415) (71,135) (25,653)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (28,415) (71,135) (25,653)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.